Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 2.25% | 93.51 | 5.5% | $179.67m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.13% | 30.30 | 14.1% | $178.29m | |
| ICLR | ICON plc | 4.47% | 205.20 | 4.2% | $131.92m | |
| CTLT | Catalent, Inc. | 1.02% | 111.03 | 2.1% | $128.45m | |
| GWPH | GW Pharmaceuticals Plc | 0.21% | 218.81 | 6.1% | $124.34m | |
| BHC | Bausch Health Cos., Inc. | 0.13% | 30.30 | 0.0% | $108.60m | |
| UTHR | United Therapeutics Corp. | -0.55% | 201.67 | 14.1% | $97.68m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.21% | 168.39 | 2.3% | $90.22m | |
| SAVA | Cassava Sciences, Inc. | -1.63% | 35.09 | 0.0% | $67.46m | |
| ARGX | argenx SE | 1.72% | 277.47 | 0.0% | $51.25m | |
| PRGO | Perrigo Co. Plc | 1.94% | 41.17 | 6.9% | $37.55m | |
| SAGE | SAGE Therapeutics, Inc. | -0.23% | 75.50 | 7.6% | $37.53m | |
| AMRN | Amarin Corp. Plc | -1.96% | 5.01 | 1.5% | $29.35m | |
| PCRX | Pacira Biosciences, Inc. | -4.45% | 66.34 | 9.9% | $27.57m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -4.02% | 20.55 | 16.8% | $22.11m |
Company Profile
argenx SE is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands.